Lumos Diagnostics Corrects Financial Report
Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics Holdings Ltd., a company at the forefront of point-of-care diagnostic technology, has issued a correction for its previously reported financial figures for the March 2024 quarter. The revision pertains to an error in calculating total available funding, which was originally overstated by including a duplicate amount. The corrected cash figures now accurately reflect the company’s financial position for future operations.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.